查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1762469

全球核酸扩增检测市场：市场规模、占有率、趋势、产业分析（依类型、应用、最终用途和地区）、未来预测（2025-2034）

Nucleic Acid Amplification Testing Market Size, Share, & Industry Analysis Report: By Type (PCR Tests, INAAT Tests, and LCR Tests), By Application, By End Use, and By Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 125 Pages | 商品交期: 最快1-2个工作天内

价格

根据 Polaris Market Research 的最新研究，预计到2034年，全球核酸扩增检测市场规模将达到 288.6亿美元。本报告深入分析了当前的市场动态，并分析了未来的市场成长。

核酸扩增检测（NAAT）是一类强大的分子技术，目的是精确定位生物样本中的特定遗传物质，包括 DNA 和 RNA。这些检测的基本原理是能够将即使是微量的目标核酸扩增到可侦测的水准。这种扩增对于实现早期准确诊断所需的高灵敏度非常重要，尤其是在处理低浓度病原体和识别可能被忽略的细微遗传变异时。 NAAT 的精准性和灵敏度使其成为现代诊断的基石，并在各个医学学科的临床决策中发挥关键作用。

传染病的威胁始终存在，包括新病原体的出现和现有病原体的复发，这使得广泛采用 NAAT 等高灵敏度诊断工具来有效控制和遏制疾病成为必要。此外，遗传性疾病的日益普及以及分子诊断在肿瘤学中的应用日益广泛，是 NAAT 市场需求趋势的关键驱动因素。分子技术的不断发展以及更快、更易用、更经济高效的NAAT 平台的开发，拓宽 NAAT 的范围和可及性，进一步促进这些重要诊断检测方法的发展。

核酸扩增检测市场：分析概论

依类型，聚合酶炼式反应（PCR）检测凭藉其高特异性、高灵敏度以及在各种诊断领域的广泛适用性，在2024年占据全球市场的最大占有率。由于对快速即时检测解决方案的需求不断成长，恆温核酸扩增技术（INAAT）检测预计将在预测期内呈现最高成长率。

依应用，传染病检测领域预计将在2024年占据最大占有率，这得益于 NAAT 在诊断和监测各种传染源方面的广泛应用。由于分子诊断在癌症管理和个人化医疗方法的应用日益广泛，肿瘤检测预计将成为成长最快的应用领域。

根据最终用途，预计中央和参考实验室将在2023年占据核酸扩增检测市场的最大占有率。由于医院日益整合先进的分子诊断技术，以加速和改善病患护理，医院市场预计将呈现最高的成长率。

根据地区，北美将在2024年占据最大的市场占有率。预计亚太地区的核酸扩增检测市场将在预测期内达到最高成长率。

活跃于该市场的主要公司包括F. Hoffmann-La Roche AG、Abbott Laboratories、Thermo Fisher Scientific Inc.、QIAGEN N.V.、bioMerieux S.A.、Becton, Dickinson and Company（BD）、Siemens Healthineers AG、Danaher Corporation（Cepheid）、Hologic, Inc.、Agilent Technologies, Inc.、Illumina, Inc.。

目录

第1章 简介

第2章 执行摘要

第3章 分析方法

第4章 全球核酸扩增检测市场洞察

  • 市场概况
  • 核酸扩增检测市场动态
    • 驱动因素与机会
      • 全球传染病患者病率上升
      • 遗传疾病发生率上升
    • 限制与挑战
      • 成本高且需要专用设备
  • PESTLE 分析
  • 核酸扩增检测市场使用趋势
  • 价值链分析
  • COVID-19 影响分析

第5章 全球核酸扩增检测市场（依类型）

  • 主要分析结果
  • 简介
  • PCR 检测
  • INAAT 侦测
  • LCR 检测

第6章 全球核酸扩增检测市场（依应用）

  • 主要分析结果
  • 简介
  • 传染病检测
  • Deep Tensor
  • 肿瘤学检测
  • 基因和粒线体疾病检测
  • 其他

第7章 全球核酸扩增检测市场（依最终用途）

  • 主要分析结果
  • 简介
  • 医院
  • 中心实验室
  • 参考实验室
  • 其他

第8章 全球核酸扩增检测市场（依地区）

  • 主要分析结果
  • 简介
    • 各地区核酸扩增检验市场分析（2020-2034）
  • 北美
    • 北美：依类型（2020-2034）
    • 北美：依应用（2020-2034）
    • 北美：依最终用途（2020-2034）
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲：依类型（2020-2034）
    • 欧洲：依应用（2020-2034）
    • 欧洲：依最终用途（2020-2034）
    • 英国
    • 法国
    • 德国
    • 义大利
    • 西班牙
    • 荷兰
    • 俄罗斯
    • 其他欧洲国家
  • 亚太地区
    • 亚太地区：依类型（2020-2034）
    • 亚太地区：依应用（2020-2034）
    • 亚太地区：依最终用途（2020-2034）
    • 中国
    • 印度
    • 马来西亚
    • 日本
    • 印尼
    • 韩国
    • 澳洲
    • 其他亚太地区
  • 中东和非洲
    • 中东和非洲：依类型（2020-2034）
    • 中东和非洲：依应用（2020-2034）
    • 中东和非洲：依最终用途（2020-2034）
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 以色列
    • 南非
    • 其他中东和非洲地区
  • 拉丁美洲
    • 拉丁美洲：依类型（2020-2034）
    • 拉丁美洲：依应用（2020-2034）
    • 拉丁美洲：依最终用途（2020-2034）
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他拉丁美洲国家

第9章 竞争格局

  • 业务扩张/收购分析
    • 业务扩张
    • 企业收购
  • 合作/协作/协议/公开

第10章 公司简介

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company（BD）
  • bioMerieux S.A.
  • Danaher Corporation（Cepheid）
  • F. Hoffmann-La Roche AG
  • Hologic, Inc.
  • Illumina, Inc.
  • QIAGEN N.V.
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
Product Code: PM5711

The global nucleic acid amplification testing market size is expected to reach USD 28.86 billion by 2034, according to a new study by Polaris Market Research. The report "Nucleic Acid Amplification Testing Market Size, Share, & Industry Analysis Report: By Type (PCR Tests, INAAT Tests, and LCR Tests), By Application, By End Use, and By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Nucleic acid amplification testing, or NAAT, constitutes a powerful suite of molecular techniques designed to pinpoint specific genetic material, encompassing both DNA and RNA, within a biological specimen. The fundamental principle of these tests lies in their capacity to amplify even trace amounts of target nucleic acids to detectable levels. This amplification is essential for achieving the high sensitivity required for early and accurate diagnosis, particularly when dealing with pathogens present in low concentrations or identifying subtle genetic variations that might otherwise go unnoticed. The precision and sensitivity offered by NAAT have established it as a cornerstone in modern diagnostics, playing a pivotal role in clinical decision-making across a spectrum of medical disciplines.

The persistent threat of infectious diseases, including the emergence of novel pathogens and the resurgence of existing ones, necessitates the widespread adoption of sensitive diagnostic tools such as NAAT for effective disease management and containment. Furthermore, the increasing prevalence of genetic disorders and the expanding application of molecular diagnostics in oncology are significant drivers for the market demand trends of NAAT. Ongoing advancements in molecular technologies, leading to the development of more rapid, user-friendly, and cost-effective NAAT platforms, are also broadening their applicability and accessibility, further contributing to the development of these crucial diagnostic assays.

Nucleic Acid Amplification Testing Market Report Highlights:

By type, the polymerase chain reaction (PCR) tests segment held the largest share globally in 2024 due to their high specificity, sensitivity, and broad applicability across various diagnostic areas. Isothermal nucleic acid amplification technology (INAAT) tests are anticipated to exhibit the highest growth rate during the forecast period, driven by the increasing demand for rapid and point-of-care testing solutions.

By application, the infectious disease testing segment constituted the largest application segment in 2024, fueled by the widespread use of NAAT for diagnosing and monitoring a wide array of infectious agents. Oncology testing is expected to be the fastest-growing application segment, driven by the increasing adoption of molecular diagnostics in cancer management and personalized medicine approaches.

By end use, the central and reference laboratories segment accounted for the largest share of the nucleic acid amplification testing market in 2023, attributed to the high volume of tests processed in these facilities and their role as key hubs for specialized testing. The hospitals segment is projected to demonstrate the highest growth rate, driven by the increasing integration of advanced molecular diagnostics within hospital settings for rapid and improved patient care.

By region, North America held the largest share of the market in 2024. The Asia Pacific nucleic acid amplification testing market is projected to record the highest growth rate during the forecast period.

A few of the major players actively operating in the market are F. Hoffmann-La Roche AG; Abbott Laboratories; Thermo Fisher Scientific Inc.; QIAGEN N.V.; bioMerieux S.A.; Becton, Dickinson and Company (BD); Siemens Healthineers AG; Danaher Corporation (Cepheid); Hologic, Inc.; Agilent Technologies, Inc.; and Illumina, Inc.

Polaris Market Research has segmented the nucleic acid amplification testing market report on the basis of type, application, end use, and region:

By Type Outlook (Revenue - USD Billion, 2020-2034)

PCR Tests

INAAT Tests

LCR Tests

By Application Outlook (Revenue - USD Billion, 2020-2034)

Infectious Disease Testing

Oncology Testing

Genetic & Mitochondrial Disease Testing

Others

By End Use Outlook (Revenue - USD Billion, 2020-2034)

Hospitals

Central

Reference Laboratories

Others

By Regional Outlook (Revenue - USD Billion, 2020-2034)

North America

US

Canada

Mexico

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Brazil

Argentina

Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Source
    • 3.2.1. Primary Source
    • 3.2.2. Secondary Source

4. Global Nucleic Acid Amplification Testing Market Insights

  • 4.1. Nucleic Acid Amplification Testing Market - Market Snapshot
  • 4.2. Nucleic Acid Amplification Testing Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising Global Prevalence of Infectious Diseases
      • 4.2.1.2. Increasing Incidence of Genetic Disorders
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High cost and need for specialized equipment
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Nucleic Acid Amplification Testing Market Application Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Nucleic Acid Amplification Testing Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • 5.3. PCR Tests
    • 5.3.1. Global Nucleic Acid Amplification Testing Market, by PCR Tests, by Region, 2020-2034 (USD Billion)
  • 5.4. INAAT Tests
    • 5.4.1. Global Nucleic Acid Amplification Testing Market, by INAAT Tests, by Region, 2020-2034 (USD Billion)
  • 5.5. LCR Tests
    • 5.5.1. Global Nucleic Acid Amplification Testing Market, by LCR Tests, by Region, 2020-2034 (USD Billion)

6. Global Nucleic Acid Amplification Testing Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • 6.3. Infectious Disease Testing
    • 6.3.1. Global Nucleic Acid Amplification Testing Market, by Infectious Disease Testing, by Region, 2020-2034 (USD Billion)
  • 6.4. Deep Tensor
    • 6.4.1. Global Nucleic Acid Amplification Testing Market, by Deep Tensor, by Region, 2020-2034 (USD Billion)
  • 6.5. Oncology Testing
    • 6.5.1. Global Nucleic Acid Amplification Testing Market, by Oncology Testing, by Region, 2020-2034 (USD Billion)
  • 6.6. Genetic & Mitochondrial Disease Testing
    • 6.6.1. Global Nucleic Acid Amplification Testing Market, by Genetic & Mitochondrial Disease Testing, by Region, 2020-2034 (USD Billion)
  • 6.7. Others
    • 6.7.1. Global Nucleic Acid Amplification Testing Market, by Others, by Region, 2020-2034 (USD Billion)

7. Global Nucleic Acid Amplification Testing Market, by End Use

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • 7.3. Hospitals
    • 7.3.1. Global Nucleic Acid Amplification Testing Market, by Hospitals, by Region, 2020-2034 (USD Billion)
  • 7.4. Central
    • 7.4.1. Global Nucleic Acid Amplification Testing Market, by Central, by Region, 2020-2034 (USD Billion)
  • 7.5. Reference Laboratories
    • 7.5.1. Global Nucleic Acid Amplification Testing Market, by Reference Laboratories, by Region, 2020-2034 (USD Billion)
  • 7.6. Others
    • 7.6.1. Global Nucleic Acid Amplification Testing Market, by Others, by Region, 2020-2034 (USD Billion)

8. Global Nucleic Acid Amplification Testing Market, by Geography

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Nucleic Acid Amplification Testing Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 8.3. Nucleic Acid Amplification Testing Market - North America
    • 8.3.1. North America: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
    • 8.3.2. North America: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
    • 8.3.3. North America: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.3.4. Nucleic Acid Amplification Testing Market - U.S.
      • 8.3.4.1. U.S.: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.3.4.2. U.S.: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.3.4.3. U.S.: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.3.5. Nucleic Acid Amplification Testing Market - Canada
      • 8.3.5.1. Canada: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.3.5.2. Canada: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.3.5.3. Canada: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • 8.4. Nucleic Acid Amplification Testing Market - Europe
    • 8.4.1. Europe: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
    • 8.4.2. Europe: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
    • 8.4.3. Europe: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.4. Nucleic Acid Amplification Testing Market - UK
      • 8.4.4.1. UK: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.4.4.2. UK: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.4.4.3. UK: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.5. Nucleic Acid Amplification Testing Market - France
      • 8.4.5.1. France: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.4.5.2. France: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.4.5.3. France: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.6. Nucleic Acid Amplification Testing Market - Germany
      • 8.4.6.1. Germany: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.4.6.2. Germany: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.4.6.3. Germany: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.7. Nucleic Acid Amplification Testing Market - Italy
      • 8.4.7.1. Italy: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.4.7.2. Italy: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.4.7.3. Italy: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.8. Nucleic Acid Amplification Testing Market - Spain
      • 8.4.8.1. Spain: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.4.8.2. Spain: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.4.8.3. Spain: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.9. Nucleic Acid Amplification Testing Market - Netherlands
      • 8.4.9.1. Netherlands: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.4.9.2. Netherlands: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.4.9.3. Netherlands: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.10. Nucleic Acid Amplification Testing Market - Russia
      • 8.4.10.1. Russia: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.4.10.2. Russia: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.4.10.3. Russia: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.11. Nucleic Acid Amplification Testing Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.4.11.2. Rest of Europe: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.4.11.3. Rest of Europe: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • 8.5. Nucleic Acid Amplification Testing Market - Asia Pacific
    • 8.5.1. Asia Pacific: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
    • 8.5.2. Asia Pacific: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
    • 8.5.3. Asia Pacific: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.4. Nucleic Acid Amplification Testing Market - China
      • 8.5.4.1. China: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.5.4.2. China: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.5.4.3. China: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.5. Nucleic Acid Amplification Testing Market - India
      • 8.5.5.1. India: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.5.5.2. India: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.5.5.3. India: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.6. Nucleic Acid Amplification Testing Market - Malaysia
      • 8.5.6.1. Malaysia: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.5.6.2. Malaysia: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.5.6.3. Malaysia: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.7. Nucleic Acid Amplification Testing Market - Japan
      • 8.5.7.1. Japan: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.5.7.2. Japan: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.5.7.3. Japan: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.8. Nucleic Acid Amplification Testing Market - Indonesia
      • 8.5.8.1. Indonesia: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.5.8.2. Indonesia: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.5.8.3. Indonesia: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.9. Nucleic Acid Amplification Testing Market - South Korea
      • 8.5.9.1. South Korea: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.5.9.2. South Korea: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.5.9.3. South Korea: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.10. Nucleic Acid Amplification Testing Market - Australia
      • 8.5.10.1. Australia: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.5.10.2. Australia: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.5.10.3. Australia: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.11. Nucleic Acid Amplification Testing Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.5.11.2. Rest of Asia Pacific: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.5.11.3. Rest of Asia Pacific: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • 8.6. Nucleic Acid Amplification Testing Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
    • 8.6.2. Middle East & Africa: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
    • 8.6.3. Middle East & Africa: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.6.4. Nucleic Acid Amplification Testing Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.6.4.2. Saudi Arabia: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.6.5. Nucleic Acid Amplification Testing Market - UAE
      • 8.6.5.1. UAE: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.6.5.2. UAE: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.6.5.3. UAE: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.6.6. Nucleic Acid Amplification Testing Market - Israel
      • 8.6.6.1. Israel: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.6.6.2. Israel: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.6.6.3. Israel: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.6.7. Nucleic Acid Amplification Testing Market - South Africa
      • 8.6.7.1. South Africa: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.6.7.2. South Africa: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.6.7.3. South Africa: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.6.8. Nucleic Acid Amplification Testing Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.6.8.2. Rest of Middle East & Africa: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.6.8.3. Rest of Middle East & Africa: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • 8.7. Nucleic Acid Amplification Testing Market - Latin America
    • 8.7.1. Latin America: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
    • 8.7.2. Latin America: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
    • 8.7.3. Latin America: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.7.4. Nucleic Acid Amplification Testing Market - Mexico
      • 8.7.4.1. Mexico: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.7.4.2. Mexico: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.7.4.3. Mexico: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.7.5. Nucleic Acid Amplification Testing Market - Brazil
      • 8.7.5.1. Brazil: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.7.5.2. Brazil: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.7.5.3. Brazil: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.7.6. Nucleic Acid Amplification Testing Market - Argentina
      • 8.7.6.1. Argentina: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.7.6.2. Argentina: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.7.6.3. Argentina: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.7.7. Nucleic Acid Amplification Testing Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.7.7.2. Rest of Latin America: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.7.7.3. Rest of Latin America: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Abbott Laboratories
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Agilent Technologies, Inc.
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Becton, Dickinson and Company (BD)
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. bioMerieux S.A.
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Danaher Corporation (Cepheid)
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. F. Hoffmann-La Roche AG
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Hologic, Inc.
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Illumina, Inc.
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. QIAGEN N.V.
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Siemens Healthineers AG
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Thermo Fisher Scientific Inc.
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development

List of Tables:

  • Table 1 Global Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 2 Global Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • Table 3 Global Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • Table 4 North America: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 5 North America: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • Table 6 North America: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • Table 7 U.S.: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 8 U.S.: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • Table 9 U.S.: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • Table 10 Canada: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 11 Canada: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • Table 12 Canada: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • Table 13 Europe: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 14 Europe: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • Table 15 Europe: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • Table 16 UK: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 17 UK: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • Table 18 UK: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • Table 19 France: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 20 France: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • Table 21 France: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • Table 22 Germany: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 23 Germany: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • Table 24 Germany: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • Table 25 Italy: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 26 Italy: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • Table 27 Italy: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • Table 28 Spain: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 29 Spain: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • Table 30 Spain: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • Table 31 Netherlands: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 32 Netherlands: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • Table 33 Netherlands: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • Table 34 Russia: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 35 Russia: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • Table 36 Russia: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • Table 37 Rest of Europe: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 38 Rest of Europe: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • Table 39 Rest of Europe: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • Table 40 Asia Pacific: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 41 Asia Pacific: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • Table 42 Asia Pacific: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • Table 43 China: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 44 China: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • Table 45 China: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • Table 46 India: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 47 India: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • Table 48 India: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • Table 49 Malaysia: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 50 Malaysia: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • Table 51 Malaysia: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • Table 52 Japan: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 53 Japan: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • Table 54 Japan: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • Table 55 Indonesia: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 56 Indonesia: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • Table 57 Indonesia: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • Table 58 South Korea: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 59 South Korea: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • Table 60 South Korea: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • Table 61 Australia: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 62 Australia: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • Table 63 Australia: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • Table 64 Rest of Asia Pacific: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 65 Rest of Asia Pacific: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • Table 66 Rest of Asia Pacific: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • Table 67 Middle East & Africa: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 68 Middle East & Africa: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • Table 69 Middle East & Africa: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • Table 70 Saudi Arabia: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 71 Saudi Arabia: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • Table 72 Saudi Arabia: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • Table 73 UAE: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 74 UAE: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • Table 75 UAE: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • Table 76 Israel: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 77 Israel: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • Table 78 Israel: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • Table 79 South Africa: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 80 South Africa: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • Table 81 South Africa: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • Table 82 Rest of Middle East & Africa: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 83 Rest of Middle East & Africa: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • Table 84 Rest of Middle East & Africa: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • Table 85 Latin America: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 86 Latin America: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • Table 87 Latin America: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • Table 88 Mexico: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 89 Mexico: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • Table 90 Mexico: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • Table 91 Brazil: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 92 Brazil: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • Table 93 Brazil: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • Table 94 Argentina: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 95 Argentina: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • Table 96 Argentina: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • Table 97 Rest of Latin America: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 98 Rest of Latin America: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • Table 99 Rest of Latin America: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)

List of Figures:

  • Figure 1. Global Nucleic Acid Amplification Testing Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Type
  • Figure 7. Global Nucleic Acid Amplification Testing Market, by Type, 2024 & 2034 (USD Billion)
  • Figure 8. Market by Application
  • Figure 9. Global Nucleic Acid Amplification Testing Market, by Application, 2024 & 2034 (USD Billion)
  • Figure 10. Market by End Use
  • Figure 11. Global Nucleic Acid Amplification Testing Market, by End Use, 2024 & 2034 (USD Billion)